Search results
Todd Waldman is a professor in the Department of Oncology in the Lombardi Cancer Center, Georgetown University School of Medicine. He also serves as Director of the Georgetown MD/PhD Program (since 2010), and as Deputy Director of the Tumor Biology Training Program. Dr. Waldman was born and raised in Bethesda, Maryland.
Dr. Todd Waldmann is a founding partner of Idaho Urologic Institute and Surgery Center of Idaho. He currently serves as president of IUI. He earned a BA in English from the University of Notre Dame and is a graduate of The Oregon Health Sciences University School of Medicine in Portland, where he also completed his.
Todd Waldman is internationally known for his discoveries in cancer research. He developed the first effective tools for gene editing, making it possible for the first time to specifically modify ...
- 364
- 375
- Georgetown University School of Medicine
Todd Waldman is known for Awkward. (2011), Single by 30 (2016) and Happy Endings (2011). Menu. Movies. Release Calendar Top 250 Movies Most Popular Movies Browse ...
- Producer, Additional Crew, Writer
- Todd Waldman
Todd Waldman is an accomplished TV writer and producer. He has written on Happy Endings (ABC), Manhattan Love Story (ABC), Awkward (MTV), as well as Bo Burnham’s Zach Stone is Gonna Be Famous (MTV). Some of Todd’s other credits include showrunning the critically acclaimed Embeds for Verizon, and YouTube’s Single By 30.
p21 Is Necessary for the p53-mediated G 1 Arrest in Human Cancer Cells. T Waldman, KW Kinzler, B Vogelstein. Cancer research 55 (22), 5187-5190. , 1995. 1658. 1995. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. F Bunz, PM Hwang, C Torrance, T Waldman, Y Zhang, L Dillehay, ...
Director – Todd Waldman, MD, PhD. Todd Waldman is a Professor of Oncology, Biochemistry, Molecular & Cellular Biology at Georgetown School of Medicine. He has been Director of the MD/PhD program since 2010. In 2011, Dr. Waldman reported the discovery of a new cancer gene named STAG2, which is inactivated by mutation in bladder cancer ...
